医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19.

广告
第一作者: Anita E,Qualls
第一单位: Department of Microbiology and Immunology, UCSF, San Francisco, California, USA.
作者单位: Department of Microbiology and Immunology, UCSF, San Francisco, California, USA. [1] Department of Pharmaceutical Chemistry, Department of Cellular and Molecular Pharmacology, and Chan Zuckerberg Biohub, UCSF, San Francisco, California, USA. [2] Institute for Systems Biology, Seattle, Washington, USA. [3] Yale School of Medicine, New Haven, Connecticut, USA. [4] Stanford University School of Medicine, Palo Alto, California, USA. [5] Icahn School of Medicine at Mount Sinai, New York, New York, USA. [6] Department of Medicine, UCSF, San Francisco, California, USA. [7] Precision Vaccines Program, Boston Children's Hospital, and. [8] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [9] The University of Texas at Austin, Austin, Texas, USA. [10] Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, USA. [11] Drexel University, Tower Health Hospital, Philadelphia, Pennsylvania, USA. [12] Baylor College of Medicine and the Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, Texas, USA. [13] University of Florida, Gainesville, Florida, USA. [14] Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA. [15] Oregon Health & Science University, Portland, Oregon, USA. [16] University of Arizona, Tucson, Arizona, USA. [17] David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA. [18] Clinical and Data Coordinating Center (CDCC), Boston Children's Hospital, Boston, Massachusetts, USA. [19] La Jolla Institute for Immunology, La Jolla, California, USA. [20] National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA. [21] Emory School of Medicine, Atlanta, Georgia, USA. [22] Swedish Center for Research and Innovation, Providence Swedish Medical Center, Seattle, Washington, USA.;Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA. [23] Department of Microbiology and Immunology, UCSF, San Francisco, California, USA.;Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. [24]
DOI 10.1172/jci.insight.191314
PMID 40402577
发布时间 2026-03-07
提交
  • 浏览2
JCI insight

JCI insight

2025年10卷13期

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷